Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
10.03
+0.15 (1.52%)
Jun 26, 2026, 1:15 PM EDT - Market open
Vir Biotechnology Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Vir Biotechnology stock has a consensus rating of "Strong Buy" and an average price target of $21.56. The average 1-year stock price forecast is 114.96% higher than the current stock price, while the lowest is $16 (+59.52%) and the highest is $30 (+199.10%).
Price Target: $21.56 (+114.96%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Vir Biotechnology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 7 | 7 | 7 | 7 | 7 |
| Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $23 → $27 | Buy | Reiterates | $23 → $27 | +169.19% | Jun 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $20 | Buy | Reiterates | $20 | +99.40% | Jun 4, 2026 |
| Barclays | Barclays | Buy Maintains $30 | Buy | Maintains | $30 | +199.10% | Jun 1, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $16 | Buy | Maintains | $16 | +59.52% | May 29, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 27, 2026 |
Financial Forecast
Revenue This Year
249.42M
from 68.56M
Increased by 263.82%
Revenue Next Year
112.90M
from 249.42M
Decreased by -54.74%
EPS This Year
-1.37
from -3.16
EPS Next Year
-2.32
from -1.37
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 320.9M | ||
| Avg | 249.4M | ||
| Low | 192.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 368.1% | ||
| Avg | 263.8% | ||
| Low | 180.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.20 | ||
| Avg | -1.37 | ||
| Low | -1.74 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |